Interventional Cardiology & Surgery
From the Journals
Transapical valve replacement relieves mitral regurgitation
“What an absolute pleasure to be a mitral surgeon at a meeting where you’re presenting a solution for something that we find incredibly...
From the Journals
Less severe strokes with LAA closure vs. DOAC in AFib?
“Despite a higher baseline risk profile, patients treated with LAAC who developed IS had better outcomes than those receiving DOAC prophylaxis.”...
Conference Coverage
Alternative antirejection regimen is efficacious in pediatric heart transplant
Results of the head-to-head TEAMMATE trial show the combination of everolimus and low-dose tacrolimus can be considered an alternative to MMF plus...
Conference Coverage
AI-ECG gets STEMI patients to cath lab sooner
An artificial intelligence electrocardiography app cut catheterization lab activation times by 9 minutes in ST-elevation myocardial infarction...
Conference Coverage
Angioplasty finally proven beneficial in stable angina: ORBITA-2
“I can say with confidence on the basis of a placebo-controlled trial that PCI certainly does have a favorable impact in patients with documented...
From the Journals
Excellent outcome of Ross procedure after 2 decades
The new evidence suggests the Ross procedure is “a truly attractive option in younger patients with long life expectancy.”
Conference Coverage
Short aspirin therapy noninferior to DAPT for 1 year after PCI for ACS
“This study provides evidence that stopping aspirin within 1 month after implantation of drug-eluting stents for ticagrelor monotherapy is a...
Conference Coverage
Drug-coated balloon beats conventional angioplasty for high-risk patients with in-stent restenosis
This device is a U.S. FDA–designated breakthrough device, “and this pivotal trial will be the primary evidence used to support FDA approval.”
Latest News
Second pig heart recipient dies
“Mr. Faucette’s last wish was for us to make the most of what we have learned from our experience, so others may be guaranteed a chance for a new...
Conference Coverage
Drug-eluting resorbable scaffold beats angioplasty for infrapopliteal artery disease
“If this technology is approved by the FDA, it will provide a new option for our patients with very difficult-to-treat disease, which will provide...
Conference Coverage
Low-risk TAVR studies: Divergent long-term results
“Cardiovascular mortality occurred at a rate of about 1% per year with both therapies, strokes at the rate of 1% per year with both therapies, and...